NASDAQ$VREX

Varex Imaging Corp · Q4 2024 earnings

Q4 2024 earnings · · Investor relations

Briefing

Varex Imaging's financial performance declined due to decrease in revenue and EPS.

Varex Imaging Corporation reported a decrease in revenue and earnings per share (EPS) for the fourth quarter of fiscal year 2024. Revenue was $206 million, and GAAP net loss per diluted share was $(1.22). The company's cash flow from operations was $26 million, and it ended the year with $213 million in cash and marketable securities.

  • Q4 revenue reached $206 million, at the high end of guidance, driven by Industrial segment strength.
  • Medical segment revenue decreased 12% year-over-year to $144 million.
  • Industrial segment revenue decreased 4% year-over-year to $61 million.
  • Cash generation was strong, with $213 million in cash and marketable securities at fiscal year-end.

Headline financials

Total Revenue

$206M

Previous: $227M-9.5%
EPS (adj)

$0.19

Previous: $0.45-57.8%
GAAP Gross Margin

32.6%

No prior period
Non-GAAP Gross Margin

32.9%

Previous: 36.0%-8.6%
GAAP Operating Margin

5.3%

No prior period
Non-GAAP Operating Margin

7.0%

Previous: 13.0%-46.2%
Capital Expenditures

-$6M

Previous: $5.4M-211.1%
Net Income

-$49.9M

Previous: $32M-255.9%
Operating Income

$10.9M

Previous: $24.3M-55.1%
Gross Profit

$67.1M

Previous: $78M-14.0%
R&D Expense

$21.9M

Previous: $21.8M+0.5%
Stock-Based Comp

$3.5M

Previous: $3.4M+2.9%

Revenue & EPS history

Varex Imaging · Revenue · Quarterly

$206M

Q4 2024-9.5%vs Q4 2023
Beat estimate in 12 of 15 quarters(80%)
ActualEstimate

Revenue by segment

Varex Imaging · $232M total across 2 segments · Q3 2023

  • Medical
    $175M+5.0%
  • Industrial
    $56.8M+19.8%

Forward guidance

For the first quarter of fiscal year 2025, Varex Imaging expects revenues between $195 million and $215 million and non-GAAP net earnings per diluted share between -$0.05 and $0.10.

Tailwinds

  • Revenues are expected between $195 million and $215 million

Headwinds

  • Non-GAAP net earnings per diluted share is expected to be between -$0.05 and $0.10

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports · overlaid with Q4 2024

Historical avgQ4 2024

-4.3%

Avg return

Earnings day

-3.4%

Avg return

5 days after

-3.0%

Avg return

30 days after

37%

15 / 41 earnings

Positive

+22.1%

Q1 2021

Best reaction

-34.7%

Q2 2020

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q2 2026-16.9%-14.9%
Q1 2026-3.8%-4.5%-23.6%
Q4 2025-13.7%-7.1%+3.6%
Q2 2025-20.5%-13.9%-2.7%
Q1 2025-19.3%-11.6%-15.7%
Q4 2024+9.2%+17.8%+1.8%
Q3 2024-12.2%-21.2%-15.6%
Q2 2024-6.0%-4.4%-6.8%
Q1 2024-8.4%-8.4%-8.6%
Q4 2023+3.1%+1.7%+12.7%
Q3 2023-3.8%-2.6%-15.5%
Q2 2023+17.6%+25.5%+25.6%
Q1 2023-10.0%-7.2%-14.6%
Q4 2022+3.8%-1.6%-10.7%
Q3 2022+4.1%-0.6%-0.3%
Q2 2022+11.5%+11.5%+15.8%
Q1 2022-5.3%-8.6%-4.8%
Q4 2021+17.1%+15.0%+8.7%
Q3 2021+1.9%+7.3%+10.2%
Q2 2021+2.6%+2.0%+6.1%
Q1 2021+22.1%+19.3%+21.0%
Q4 2020-3.2%+1.0%+16.6%
Q3 2020-21.2%-21.1%-34.3%
Q2 2020-34.7%-32.9%-38.3%
Q1 2020-5.3%-5.3%-25.3%
Q4 2019-9.7%-7.5%-3.5%
Q3 2019-15.8%-13.3%-5.0%
Q2 2019-9.1%-8.1%-16.4%
Q1 2019+15.7%+8.8%+15.0%
Q4 2018-8.3%-1.8%-10.8%
Q3 2018-25.7%-25.5%-17.8%
Q2 2018-1.6%-0.3%+1.1%
Q1 2018-18.5%-15.9%-15.8%
Q4 2015-1.2%-0.2%+7.2%
Q4 2017+1.8%+2.6%+10.3%
Q3 2016+0.8%-0.2%+9.4%
Q3 2017-8.2%-5.1%+1.3%
Q2 2016+0.2%+0.2%-3.3%
Q2 2017+0.7%+1.2%+3.0%
Q1 2017-2.4%-5.1%-0.3%
Q4 2016-2.4%-5.1%-0.3%
Q1 2016

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro